+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vascular Grafts (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 89 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5460007
Vascular Grafts (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Summary


This Medical Devices sector report, “Vascular Grafts (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Vascular Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. These are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Vascular Grafts Overview
3 Products under Development
3.1 Vascular Grafts - Pipeline Products by Stage of Development
3.2 Vascular Grafts - Pipeline Products by Segment
3.3 Vascular Grafts - Pipeline Products by Territory
3.4 Vascular Grafts - Pipeline Products by Regulatory Path
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date1
3.6 Vascular Grafts - Ongoing Clinical Trials
4 Vascular Grafts - Pipeline Products under Development by Companies
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development
4.2 Vascular Grafts - Pipeline Products by Stage of Development
5 Vascular Grafts Companies and Product Overview
5.1 3DT Holdings LLC Company Overview
5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Andes University Company Overview
5.2.1 Andes University Pipeline Products & Ongoing Clinical Trials Overview
5.3 Angiograft LLC Company Overview
5.3.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Ariste Medical LLC Company Overview
5.4.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Aruga Technologies LLC Company Overview
5.5.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 BioDGraft GmbH Company Overview
5.6.1 BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.7 BioIntegral Surgical Inc Company Overview
5.7.1 BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Biosurfaces Inc Company Overview
5.8.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Cardiojustable LLC (Inactive) Company Overview
5.9.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cardiovate Company Overview
5.10.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
5.11 Colorado Therapeutics, LLC Company Overview
5.11.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 CryoLife Inc Company Overview
5.12.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.13.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 DSM Biomedical BV Company Overview
5.14.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
5.15 Eqalix Inc Company Overview
5.15.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 FIT Biotech Oy (Inactive) Company Overview
5.16.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.17 Gel-Del Technologies, Inc. Company Overview
5.17.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 Humacyte Inc Company Overview
5.18.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Innovia LLC Company Overview
5.19.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.20 Merit Medical Systems Inc Company Overview
5.20.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 MicroPort Scientific Corp Company Overview
5.21.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.22 Nationwide Children's Hospital Company Overview
5.22.1 Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.23 Northwestern University Company Overview
5.23.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.24 Peca Labs Inc Company Overview
5.24.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 PetVivo Holdings Inc Company Overview
5.25.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 PQ Bypass Inc Company Overview
5.26.1 PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 RegenaGraft Company Overview
5.27.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
5.28 RUA Vascular Ltd Company Overview
5.28.1 RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 Secant Group LLC Company Overview
5.29.1 Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
5.30 Southern University of Science and Technology Company Overview
5.30.1 Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
5.31 STENTiT Company Overview
5.31.1 STENTiT Pipeline Products & Ongoing Clinical Trials Overview
5.32 Tgen Tech LLC Company Overview
5.32.1 Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview
5.33 Transmural systems LLC Company Overview
5.33.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
5.34 TTK Healthcare Ltd Company Overview
5.34.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 University of Louisville Company Overview
5.35.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
5.36 University of Pittsburgh Company Overview
5.36.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.37 Vascudyne Inc Company Overview
5.37.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
5.38 VenoStent Inc Company Overview
5.38.1 VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 VesselTek BioMedical LLC Company Overview
5.39.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.40 VESSL Therapeutics Ltd Company Overview
5.40.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Vascular Grafts- Recent Developments
6.1 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
6.2 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.3 Aug 30, 2021: Humacyte announces issuance of three additional U.S. patents covering its proprietary universally implantable bioengineered human tissue platform
6.4 Jul 29, 2021: LeMaitre Q2 2021 Financial Results
6.5 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
6.6 Jul 28, 2021: LifeNet Health features revolutionary biologics for wounds at APMA Annual Scientific Meeting
6.7 Jul 27, 2021: ForwardVue Pharma Appoints Bob Katz as Chief Executive Officer
6.8 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
6.9 Jul 15, 2021: LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021
6.10 Jul 13, 2021: LeMaitre Provides Q2 2021 Update
6.11 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.12 Apr 29, 2021: CryoLife Reports First Quarter 2021 Financial Results
6.13 Apr 29, 2021: LeMaitre Q1 2021 Financial Results
6.14 Apr 14, 2021: LeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021
6.15 Mar 09, 2021: CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference
6.16 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.17 Feb 11, 2021: CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results
6.18 Jan 28, 2021: CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results
6.19 Oct 21, 2020: CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Vascular Grafts - Pipeline Products by Stage of Development
  • Vascular Grafts - Pipeline Products by Segment
  • Vascular Grafts - Pipeline Products by Territory
  • Vascular Grafts - Pipeline Products by Regulatory Path
  • Vascular Grafts - Pipeline Products by Estimated Approval Date
  • Vascular Grafts - Ongoing Clinical Trials
  • Vascular Grafts Companies - Pipeline Products by Stage of Development
  • Vascular Grafts - Pipeline Products by Stage of Development
  • 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
  • PVP Biological Patch - Product Status
  • PVP Biological Patch - Product Description
  • Small Peripheral Vessel Graft - Product Status
  • Small Peripheral Vessel Graft - Product Description
  • Andes University Pipeline Products & Ongoing Clinical Trials Overview
  • SiSgraft - Product Status
  • SiSgraft - Product Description
  • Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Vascular Graft - Product Status
  • Vascular Graft - Product Description
  • Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Drug Eluting Vascular Graft - Product Status
  • Drug Eluting Vascular Graft - Product Description
  • Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Topograft - Product Status
  • Topograft - Product Description
  • BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Biodegradable Graft - Arteriosclerosis - Product Status
  • Biodegradable Graft - Arteriosclerosis - Product Description
  • BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Non-valved Conduit - Product Status
  • Non-valved Conduit - Product Description
  • BioIntegral Surgical Inc - Ongoing Clinical Trials Overview
  • Non-valved Conduit - Vascular No-react Graft Against Infection
  • Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
  • BioFunc - APC Vascular Graft - Product Status
  • BioFunc - APC Vascular Graft - Product Description
  • Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Adjustable SPA Shunt - Product Status
  • Adjustable SPA Shunt - Product Description
  • Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
  • NeoVessel Vascular Graft - Product Status
  • NeoVessel Vascular Graft - Product Description
  • Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Xenograft Implant - Peripheral Vascular Disease - Product Status
  • Xenograft Implant - Peripheral Vascular Disease - Product Description
  • CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Synergraft Xenograft Vascular Graft - Product Status
  • Synergraft Xenograft Vascular Graft - Product Description
  • Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Lifeline TEBV - Lower Limb - Product Status
  • Lifeline TEBV - Lower Limb - Product Description
  • LifeLine TEBV - Pediatric - Product Status
  • LifeLine TEBV - Pediatric - Product Description
  • DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
  • Small Diameter Vascular Graft - Product Status
  • Small Diameter Vascular Graft - Product Description
  • Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • CardioVessel - Product Status
  • CardioVessel - Product Description
  • LCL Graft - Product Status
  • LCL Graft - Product Description
  • FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • GTU X-Graft - Product Status
  • GTU X-Graft - Product Description
  • GTU X2-Graft - Product Status
  • GTU X2-Graft - Product Description
  • Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • VasoGraft - Product Status
  • VasoGraft - Product Description
  • Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
  • HUMACYL - Peripheral Artery Disease - Product Status
  • HUMACYL - Peripheral Artery Disease - Product Description
  • HUMACYL Graft - CABG - Product Status
  • HUMACYL Graft - CABG - Product Description
  • HUMACYL Graft - Vascular Trauma - Product Status
  • HUMACYL Graft - Vascular Trauma - Product Description
  • Humacyte Inc - Ongoing Clinical Trials Overview
  • HUMACYL Graft - Vascular Trauma - A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma
  • HUMACYL - Peripheral Artery Disease - A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-popliteal Bypass in Patients with Peripheral Arterial Disease
  • Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 4mm Vascular Graft - Product Status
  • 4mm Vascular Graft - Product Description
  • Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Self-expanding Covered Stent Graft - Product Status
  • Self-expanding Covered Stent Graft - Product Description
  • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Coronary Stent Graft System - Product Status
  • Coronary Stent Graft System - Product Description
  • Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Second-Generation Tissue Engineered Vascular Graft - Product Status
  • Second-Generation Tissue Engineered Vascular Graft - Product Description
  • Nationwide Children's Hospital - Ongoing Clinical Trials Overview
  • Second-Generation Tissue Engineered Vascular Graft - Prospective, Open-labelled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection
  • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • ePTFE Graft - Peripheral Arterial Disease - Product Status
  • ePTFE Graft - Peripheral Arterial Disease - Product Description
  • Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Expandable Vascular Graft - Product Status
  • Expandable Vascular Graft - Product Description
  • PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Peripheral Vascular Graft - Product Status
  • Peripheral Vascular Graft - Product Description
  • PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview
  • TORUS Stent Graft System - Product Status
  • TORUS Stent Graft System - Product Description
  • PQ Bypass Inc - Ongoing Clinical Trials Overview
  • TORUS Stent Graft System - Long Segment Lesion Peripheral Artery Revascularization Feasibility Study
  • TORUS Stent Graft System - The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2
  • RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
  • RegenaVasc - Product Status
  • RegenaVasc - Product Description
  • RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Elast-Eon Large Bore Vascular Graft - Product Status
  • Elast-Eon Large Bore Vascular Graft - Product Description
  • Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Regenerative Cardiovascular Graft - Product Status
  • Regenerative Cardiovascular Graft - Product Description
  • Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Artificial Blood Vessel - Product Status
  • Artificial Blood Vessel - Product Description
  • STENTiT Pipeline Products & Ongoing Clinical Trials Overview
  • Regenerative Stent - Product Status
  • Regenerative Stent - Product Description
  • Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview
  • TxGuard - Product Status
  • TxGuard - Product Description
  • Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Transcatheter Cavopulmonary Bypass Endograft - Product Status
  • Transcatheter Cavopulmonary Bypass Endograft - Product Description
  • TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Chitra Vascular Graft - Product Status
  • Chitra Vascular Graft - Product Description
  • University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
  • Vascular Graft System - Product Status
  • Vascular Graft System - Product Description
  • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • Biomimetic Vascular Graft - Product Status
  • Biomimetic Vascular Graft - Product Description
  • Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Small-Diameter Vascular Conduit - Product Status
  • Small-Diameter Vascular Conduit - Product Description
  • VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview
  • SelfWrap - Product Status
  • SelfWrap - Product Description
  • VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • VTek Graft - Product Status
  • VTek Graft - Product Description
  • VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • MultiGeneGraft - Product Status
  • MultiGeneGraft - Product Description
  • Glossary

List of Figures
  • Vascular Grafts - Pipeline Products by Stage of Development
  • Vascular Grafts - Pipeline Products by Segment
  • Vascular Grafts - Pipeline Products by Territory
  • Vascular Grafts - Pipeline Products by Regulatory Path
  • Vascular Grafts - Pipeline Products by Estimated Approval Date
  • Vascular Grafts - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3DT Holdings LLC
  • Andes University
  • Angiograft LLC
  • Ariste Medical LLC
  • Aruga Technologies LLC
  • BioDGraft GmbH
  • BioIntegral Surgical Inc
  • Biosurfaces Inc
  • Cardiojustable LLC (Inactive)
  • Cardiovate
  • Colorado Therapeutics, LLC
  • CryoLife Inc
  • Cytograft Tissue Engineering Inc (Inactive)
  • DSM Biomedical BV
  • Eqalix Inc
  • FIT Biotech Oy (Inactive)
  • Gel-Del Technologies, Inc.
  • Humacyte Inc
  • Innovia LLC
  • Merit Medical Systems Inc
  • MicroPort Scientific Corp
  • Nationwide Children's Hospital
  • Northwestern University
  • Peca Labs Inc
  • PetVivo Holdings Inc
  • PQ Bypass Inc
  • RegenaGraft
  • RUA Vascular Ltd
  • Secant Group LLC
  • Southern University of Science and Technology
  • STENTiT
  • Tgen Tech LLC
  • Transmural systems LLC
  • TTK Healthcare Ltd
  • University of Louisville
  • University of Pittsburgh
  • Vascudyne Inc
  • VenoStent Inc
  • VesselTek BioMedical LLC
  • VESSL Therapeutics Ltd